Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

clinical trial

Wikidata entity: Q63806918



Quantities

P2899minimum age18
P1132number of participants197

P6099 clinical trial phase ... Q42825046 (phase IV clinical trial) phase IV clinical trial
P582 end time ... 2014-07-01 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P1050 medical condition ... Q154869 (hepatitis C) hepatitis C
P1050 medical condition ... Q131742 (hepatitis) hepatitis
P4844 research intervention ... Q20817235 (interferon-alpha) interferon-alpha
P6153 research site ... Q1433199 (Indiana University – Purdue University Indianapolis) Indiana University – Purdue University Indianapolis
P6153 research site ... Q2415975 (Columbia University Irving Medical Center) Columbia University Irving Medical Center
P6153 research site ... Q5721418 (Henry Ford Health) Henry Ford Health
P6153 research site ... Q7681712 (Tampa General Hospital) Tampa General Hospital
P6153 research site ... Q30254036 (Temple University Hospital) Temple University Hospital
P6153 research site ... Q30254145 (University of Iowa Health Care) University of Iowa Health Care
P6153 research site ... Q30269889 (Florida Center for Gastroenterology) Florida Center for Gastroenterology
P1813 short name Monolingualtext OPTIMAL ???
P580 start time ... 2011-12-01 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext Boceprevir in Community Practice: Assessing Safety, Efficacy, Compliance and Quality of Life, Impact of an Education Program ???

External Ids
P3098ClinicalTrials.gov IDNCT01405027

Why not click here or view trends?

log id: 4416682